Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Sanara MedTech (SMTI) over the last 10 years, with Q3 2025 value amounting to $8.9 million.

  • Sanara MedTech's Shares Outstanding (Diluted Average) rose 497.05% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 497.05%. This contributed to the annual value of $8.5 million for FY2024, which is 247.95% up from last year.
  • As of Q3 2025, Sanara MedTech's Shares Outstanding (Diluted Average) stood at $8.9 million, which was up 497.05% from $8.6 million recorded in Q2 2025.
  • Sanara MedTech's 5-year Shares Outstanding (Diluted Average) high stood at $8.9 million for Q3 2025, and its period low was $7.9 million during Q4 2022.
  • For the 4-year period, Sanara MedTech's Shares Outstanding (Diluted Average) averaged around $8.4 million, with its median value being $8.4 million (2023).
  • In the last 5 years, Sanara MedTech's Shares Outstanding (Diluted Average) skyrocketed by 77.53% in 2023 and then surged by 497.05% in 2025.
  • Sanara MedTech's Shares Outstanding (Diluted Average) (Quarter) stood at $7.9 million in 2022, then rose by 4.71% to $8.3 million in 2023, then grew by 2.48% to $8.5 million in 2024, then rose by 5.38% to $8.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $8.9 million in Q3 2025, compared to $8.6 million in Q2 2025 and $8.6 million in Q1 2025.